leisure time -WSS

leisure time

author：leisure time 2025-09-28 01:16:38 - browse：38648

Photograph of Ron DeSantis pointing. -- health policy coverage from STAT — Florida Gov. and GOP presidential candidate Ron DeSantis wants to import Canadian prescription drugs. Charlie Neibergall/AP

WASHINGTON — Florida governor and presidential hopeful Ron DeSantis has ballyhooed a high-profile plan to import prescription drugs from Canada, even suing the Biden administration for allegedly holding up a necessary sign-off.

But the plan’s long odds just got longer: the Food and Drug Administration said in a letter last week that Florida’s plan has gaping holes — and the state has less than a week to explain how it’ll fix them.

The FDA “identified several deficiencies,” in the drug-import plan, it said. Despite its thousands of pages, the plan does not show whether it meets the two overarching requirements of saving money and securing the drug supply chain, the agency explained. The FDA gave the state until August 28 to flesh out those two subjects.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： American taxpayers paid $1.8 trillion in health care costs in 2022

hotspot

leisure time

WSS

Ascension's ugly legal battle over care for poor patients in Texas

Does Paxlovid work in people vaccinated against Covid

Arena BioWorks launches in Cambridge to speed drug discovery

Medicare drug price negotiation continues, as pharma counteroffers

Ancient Greek ideas underpin modern concepts of pregnancy

Stories you might have missed in 2023: health, science, medicine

knowledge

leisure time

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Change Healthcare: What is it, why does its cyberattack matter?

The cancer drug shortage isn’t new — and neither are the solutions

JPM pitch from hospitals? Revenue streams outside of patient care

United colonoscopy coverage change 'may cost lives,' doctors say

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

DIEP, the 'gold standard' of breast reconstruction, is under threat

For AI in health care standards, federal regulators join with industry group

23andMe had bad news about my health. I wish a person had delivered it

He's 19 months old and has one of the world’s rarest diseases

entertainment

Change Healthcare: What is it, why does its cyberattack matter?

Nonprofit, backed by Microsoft, to certify AI tools in health care

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Why Talkspace is targeting Medicare, a tricky market

Allen Institute goes after foundational questions, CEO Costa says

Medicare drug price negotiation continues, as pharma counteroffers

hotspot

focus

leisure time

leisure time